2024 Global Coagulation Testing Market: Unmet Needs, Supplier Shares and Strategies, Segment Volume and Sales Volume and Sales Forecasts for Major Hemostasis Assays, Emerging Technologies and Trends, Instrumentation Pipeline, Growth Opportunities
This new report from LeadingMarketResearch.com contains 650 pages, 150 tables and provides forecasts for 40 major procedures, as well as sales and market shares for reagent and instrument suppliers by country.The report is available by section, and can be customized to specific information needs and budget.This comprehensive seven-country report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the coagulation market during the next five years. The report explores business and technological trends in the US, five major European countries (France, Germany, Italy, Spain, UK) and Japan; provides estimates of the test volume, instrument placements and installed base, as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromagenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, computers and laboratory automation will radically change the coagulation testing practice during the next five years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing will also become more standardized, offering opportunities for quality control products and services. Moreover, continuing contraction of the hospital system and technological advances will facilitate decentralization of the coagulation testing closer to the patient, thus creating additional opportunities and challenges for suppliers.Contains 650 pages and 150 tables.
I. Introduction
II. Major Product Development Opportunities
III. Design Criteria For Decentralized Testing Products
IV. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
V. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VI. Worldwide Market and Technology Overview
A. Major Routine and Special Coagulation Tests
1. INTRODUCTION
2. ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT)
3. ALPHA-2 ANTIPLASMIN
4. ANTITHROMBIN III
5. BLEEDING TIME
6. D-DIMER
7. ETHANOL FLOCCULATION TEST
8. EUGLOBULIN LYSIS
9. FACTOR ASSAYS
a. Introduction
b. Factor II
c. Factor V/Factor V Leiden
d. Factor VII
e. Factor VIII
f. Factor IX
g. Factor IXa
h. Factor X (Stuart Factor)
i. Factor Xa
j. Factor XI
k. Factor XII
l. Factor XIII
Table of Contents (continued)
10. FIBRIN DEGRADATION PRODUCTS
11. FIBRINOGEN
12. HEPARIN
13. HIRUDIN
14. HYPERCOAGULABILITY AND THROMBOSIS
15. LIPOPROTEIN A
16. PLASMIN
17. PLASMINOGEN
18. PLASMINOGEN ACTIVATOR INHIBITOR (PAI)
19. PLATELET FUNCTION TESTS
20. PLATELET AGGREGATION
21. PROTEINS C AND S
22. PROTHROMBIN FRAGMENT 1.2
23. PROTHROMBIN TIME (PT)
24. REPTILASE TIME
25. THROMBIN TIME
26. TISSUE-TYPE PLASMINOGEN ACTIVATOR (T-PA)
27. VON WILLEBRAND'S FACTOR
B. Coagulation Instrumentation Review: Centralized
and POC Testing Analyzers
C. Major Coagulation Testing Technologies
and Their Potential Applications
1. CHROMOGENIC SUBSTRATES
2. MONOCLONAL AND POLYCLONAL ANTIBODIES
3. IMMUNOASSAYS
4. MOLECULAR DIAGNOSTICS
5. MICROCOMPUTERS
6. AUTOMATION
7. ROBOTICS
8. ARTIFICIAL INTELLIGENCE
9. DRY CHEMISTRY
10. BISENSORS
VII. Country Market Size, Test Volume
and Sales Forecasts by Segment, Major
Instrument and Reagent Suppliers Market
Shares
II. Major Product Development Opportunities
III. Design Criteria For Decentralized Testing Products
IV. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
V. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VI. Worldwide Market and Technology Overview
A. Major Routine and Special Coagulation Tests
1. INTRODUCTION
2. ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT)
3. ALPHA-2 ANTIPLASMIN
4. ANTITHROMBIN III
5. BLEEDING TIME
6. D-DIMER
7. ETHANOL FLOCCULATION TEST
8. EUGLOBULIN LYSIS
9. FACTOR ASSAYS
a. Introduction
b. Factor II
c. Factor V/Factor V Leiden
d. Factor VII
e. Factor VIII
f. Factor IX
g. Factor IXa
h. Factor X (Stuart Factor)
i. Factor Xa
j. Factor XI
k. Factor XII
l. Factor XIII
Table of Contents (continued)
10. FIBRIN DEGRADATION PRODUCTS
11. FIBRINOGEN
12. HEPARIN
13. HIRUDIN
14. HYPERCOAGULABILITY AND THROMBOSIS
15. LIPOPROTEIN A
16. PLASMIN
17. PLASMINOGEN
18. PLASMINOGEN ACTIVATOR INHIBITOR (PAI)
19. PLATELET FUNCTION TESTS
20. PLATELET AGGREGATION
21. PROTEINS C AND S
22. PROTHROMBIN FRAGMENT 1.2
23. PROTHROMBIN TIME (PT)
24. REPTILASE TIME
25. THROMBIN TIME
26. TISSUE-TYPE PLASMINOGEN ACTIVATOR (T-PA)
27. VON WILLEBRAND'S FACTOR
B. Coagulation Instrumentation Review: Centralized
and POC Testing Analyzers
C. Major Coagulation Testing Technologies
and Their Potential Applications
1. CHROMOGENIC SUBSTRATES
2. MONOCLONAL AND POLYCLONAL ANTIBODIES
3. IMMUNOASSAYS
4. MOLECULAR DIAGNOSTICS
5. MICROCOMPUTERS
6. AUTOMATION
7. ROBOTICS
8. ARTIFICIAL INTELLIGENCE
9. DRY CHEMISTRY
10. BISENSORS
VII. Country Market Size, Test Volume
and Sales Forecasts by Segment, Major
Instrument and Reagent Suppliers Market
Shares
